Annual Current Liabilities
$14.04 M
+$6.86 M+95.42%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual total current liabilities is $14.04 million, with the most recent change of +$6.86 million (+95.42%) on December 31, 2023.
- During the last 3 years, ANTX annual current liabilities has risen by +$12.58 million (+862.51%).
- ANTX annual current liabilities is now at all-time high.
Performance
ANTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$10.02 M
-$110.00 K-1.09%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly total current liabilities is $10.02 million, with the most recent change of -$110.00 thousand (-1.09%) on September 30, 2024.
- Over the past year, ANTX quarterly current liabilities has dropped by -$646.00 thousand (-6.06%).
- ANTX quarterly current liabilities is now -32.50% below its all-time high of $14.84 million, reached on September 30, 2023.
Performance
ANTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ANTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.4% | -6.1% |
| 3 y3 years | +862.5% | -6.1% |
| 5 y5 years | +862.5% | -6.1% |
ANTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +313.6% | -32.5% | +195.1% |
| 5 y | 5-year | at high | +862.5% | -32.5% | +195.1% |
| alltime | all time | at high | +862.5% | -32.5% | +195.1% |
AN2 Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.02 M(-1.1%) |
| Jun 2024 | - | $10.13 M(-5.0%) |
| Mar 2024 | - | $10.66 M(-24.1%) |
| Dec 2023 | $14.04 M(+95.4%) | $14.04 M(-5.4%) |
| Sep 2023 | - | $14.84 M(+33.0%) |
| Jun 2023 | - | $11.16 M(+30.3%) |
| Mar 2023 | - | $8.57 M(+19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $7.19 M(+111.7%) | $7.19 M(+62.1%) |
| Sep 2022 | - | $4.43 M(+6.8%) |
| Jun 2022 | - | $4.15 M(-18.4%) |
| Mar 2022 | - | $5.09 M(+49.8%) |
| Dec 2021 | $3.40 M(+132.7%) | - |
| Dec 2021 | - | $3.40 M |
| Dec 2020 | $1.46 M | - |
FAQ
- What is AN2 Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for AN2 Therapeutics?
- What is AN2 Therapeutics annual current liabilities year-on-year change?
- What is AN2 Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly current liabilities year-on-year change?
What is AN2 Therapeutics annual total current liabilities?
The current annual current liabilities of ANTX is $14.04 M
What is the all time high annual current liabilities for AN2 Therapeutics?
AN2 Therapeutics all-time high annual total current liabilities is $14.04 M
What is AN2 Therapeutics annual current liabilities year-on-year change?
Over the past year, ANTX annual total current liabilities has changed by +$6.86 M (+95.42%)
What is AN2 Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ANTX is $10.02 M
What is the all time high quarterly current liabilities for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly total current liabilities is $14.84 M
What is AN2 Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ANTX quarterly total current liabilities has changed by -$646.00 K (-6.06%)